Northwestern Medicine scientists have developed a method for identifying reactive cysteines on peptide antigens within the ...

On the battleground of the human body, microbes use every skill to mask, infiltrate, manipulate, and evade the immune radar.

This study demonstrates the development of PAGERs (programmable antigen-gated engineered receptors), combining antigen ...

Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated ...

Therapeutics is pleased to showcase its survival and clinical benefit data in MBC patients, including those with CNS ...

The BEXMAB study is a multicenter study, taking place in Finland, UK and the U.S., evaluating the safety and efficacy of bexmarilimab, a novel anti-Clever-1 humanized antibody, with standard of care ...

Even with cancer-associated antigens studding their surfaces, tumor cells can still escape attack by presenting a checkpoint protein, which is built to turn off the T cell. Immune checkpoint ...

B cells also exacerbate disease through the production of inflammatory cytokines and acting as antigen-presenting cells (34). The presence of B cells in diseased tissues and the positive response to ...